BUDGET IMPACT MODELLING FOR ALEMTUZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS IN COLOMBIA

被引：0
|
作者：
Londono, S. [1 ]
Gomez, N. [1 ]
机构：
[1] Sanofi, Bogota, Cun, Colombia
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND19
引用
收藏
页码：S625 / S625
页数：1
相关论文
共 50 条
  • [31] Impact of Pregnancy on the Course of Relapsing-Remitting Multiple Sclerosis
    Manganas, Alexandra
    Karp, Igor
    Roger, Elaine
    Duquette, Pierre
    [J]. NEUROLOGY, 2011, 76 (09) : A610 - A610
  • [32] The impact of pregnancy on progression of relapsing-remitting multiple sclerosis
    Karp, I.
    Manganas, A.
    Sylvestre, M. -P.
    Roger, E.
    Ho, A.
    Duquette, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 102 - 103
  • [33] Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis
    María Rosario Blasco
    Antonio Ramos
    Celia García Malo
    Antonio García-Merino
    [J]. Journal of Neurology, 2017, 264 : 168 - 169
  • [34] Sustained Positive Effects of Alemtuzumab on Diverse Neurological Functions in Relapsing-Remitting Multiple Sclerosis Patients
    Fox, Edward
    [J]. NEUROLOGY, 2010, 74 (09) : A417 - A418
  • [35] Treatment with alemtuzumab after fingolimod in relapsing-remitting multiple sclerosis is effective and safe
    Alcala, C.
    Gascon, F.
    Perez-Miralles, F.
    Dominguez, J. A.
    Garcia Gil-Perotin, S.
    Casanova, B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 274 - 274
  • [36] Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis
    Zhang, Jian
    Shi, Shengliang
    Zhang, Yueling
    Luo, Jiefeng
    Xiao, Yousheng
    Meng, Lian
    Yang, Xiaobo
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11):
  • [37] Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis
    Rosario Blasco, Maria
    Ramos, Antonio
    Garcia Malo, Celia
    Garcia-Merino, Antonio
    [J]. JOURNAL OF NEUROLOGY, 2017, 264 (01) : 168 - 169
  • [38] Cerebral toxoplasmosis in patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab
    Raquel, Calle-Calle
    Lucia, Triguero-Cueva
    Carmen, Valderrama-Martin
    Ana, Romero-Villarrubia
    Antonio, Tapia-Gomez
    Juan, Pasquau-Liano
    Carmen, Arnal-Garcia
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39
  • [39] Alemtuzumab/fingolimodSevere activation of relapsing-remitting multiple sclerosis: 3 case reports
    [J]. Reactions Weekly, 2018, 1714 (1) : 25 - 25
  • [40] Immunogenicity of alemtuzumab treatment for relapsing-remitting multiple sclerosis: no effect on efficacy or safety
    Selmaj, K.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S247 - S247
12345